Treatment of acute heart failure in an infant after cardiac surgery using levosimendan

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 1, 2004, Pages 228-230

  Braun, Jan Peter ^a   Schneider, Martin ^a   Kastrup, Marc ^a   Liu, Jianshi ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcium sensitizer; Levosimendan; Neonatal cardiac surgery; Postoperative resuscitation

Indexed keywords

LEVOSIMENDAN;

ACUTE HEART FAILURE; ARTICLE; BRADYCARDIA; CASE REPORT; CONGENITAL HEART MALFORMATION; DIURESIS; FEMALE; HEART ARREST; HEART LEFT VENTRICLE FAILURE; HEART RIGHT LEFT SHUNT; HEART SURGERY; HUMAN; INFANCY; INFANT; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESUSCITATION; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR RESISTANCE;

CARDIOTONIC AGENTS; FEMALE; HEART ARREST; HEART DEFECTS, CONGENITAL; HUMANS; HYDRAZONES; INFANT; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES;

EID: 2942596450     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.03.034     Document Type: Article

References (10)

1. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., Harjola V.P., Mitrovic V., Abdalla M., Sandell E.P., Lehtonen L. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 360:(9328):2002;196-202
2. Moiseyev V.S., Poder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., Kobalava Z.D., Lehtonen L.A., Laine T., Nieminen M.S., Lie K.I. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J. 23:(18):2002;1422-1432
3. Jamali I.N., Kersten J.R., Pagel P.S., Hettrick D.A., Warltier D.C. Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesth Analg. 85:(1):1997;23-29
4. Nijhawan N., Nicolosi A.C., Montgomery M.W., Aggarwal A., Pagel P.S., Warltier D.C. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol. 34:(2):1999;219-228
5. Lilleberg J., Nieminen M.S., Akkila J., Heikkila L., Kuitunen A., Lehtonen L., Verkkala K., Mattila S., Salmenpera M. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 19:(4):1998;660-668
6. Sundberg S., Lilleberg J., Nieminen M.S., Lehtonen L. Hemodynamic and neurohormonal effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am J Cardiol. 75:1995;1061-1066
7. Kersten J.R., Montgomery M.W., Pagel P.S., Warltier D.C. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg. 90:(1):2000;5-11
8. De Witt B.J., Ibrahim I.N., Bayer E., Fields A.M., Richards T.A., Banister R.E., Kaye A.D. An analysis of responses to levosimendan in the pulmonary vascular bed of the cat. Anesth Analg. 94:(6):2002;1427-1433
9. Bowman P., Haikala H., Paul R.J. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther. 288:(1):1999;316-325
10. Pataricza J., Hohn J., Petri A., Balogh A., Papp J.G. Comparison of the vasorelaxing effect of cromakalim and the new inodilator, levosimendan, in human isolated portal vein. J Pharm Pharmacol. 52:(2):2000;213-217